This longitudinal study determines that response to cognitive behavioral therapy (CBT) can be predicted on an individual-patient level based on functional neuroimaging data in panic disorder and agoraphobia.
This Special Communication examines the degree to which modern operationalized diagnostic criteria for schizophrenia reflect the main clinical features of the disorder as described historically by diagnostic experts.
This quasi-experimental study shows that a mental health intervention integrated into an employment training program can reduce depressive symptoms and improve engaged coping strategies in adolescents and young adults.
This genetic analysis examines whether neuronal activity-dependent changes of gene expression are dysregulated in schizophrenia.
This Viewpoint addresses suicide prevention in the context of successful lay-led disease advocacy efforts.
This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013.
This randomized trial compares the effects of metformin vs placebo on weight gain in children and adolescents with autism spectrum disorder taking atypical antipsychotics.
This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.
This cohort study examines whether quantified neural function in social perception circuits can serve as an individual-level marker of autism spectrum disorder in children and adolescents.
This epigenome-wide association study examines differentially methylated positions across the genome in blood-derived DNA samples in a discovery and a replication set.
Hall et al identify large-scale resting-state networks in patients with fragile X syndrome that differ from those in control individuals matched on age, IQ, and severity of behavioral and cognitive symptoms.